Latest Administration News

Fluence Corporation Limited reported a positive net operating cash flow of US$3.824 million for the December 2025 quarter, ending with a strong cash position of US$16.64 million. The company’s disciplined spending and financing activities underpin its stable liquidity outlook.

Spectur Limited reported a 4.5% increase in quarterly revenue to $2.02 million and secured $2.15 million through a share placement to fund its AI-driven Sense-Think-Act platform development.

Micro-X Ltd has secured a historic $3.3 million order for its Rover mobile X-ray units in Malaysia, alongside a $6.2 million capital raise to fuel its expanding medical imaging and security technology pipeline.

Coda Minerals secured $12.33 million in capital to advance a major drilling campaign and pre-feasibility study at its Elizabeth Creek copper-silver project, maintaining a strong cash position as commodity prices surge.

Ardiden Limited has completed its merger with Lac Gold, bolstering its position with a $10 million capital raise and launching a significant drilling campaign at the Rouyn Gold Project in Québec.

OM Holdings has fulfilled all conditions to sell its 26% stake in Ntsimbintle Mining to Exxaro Resources for approximately US$101.4 million, setting the stage for transaction completion by late February 2026.

Region Group (RGN) has outlined the tax breakdown of its 6.9 cents per security distribution for the half year ended December 2025, clarifying implications for non-resident investors and withholding tax obligations.

Lumos Diagnostics reported a strong surge in FebriDx® sales alongside positive FDA feedback, securing full Medicare reimbursement and advancing key clinical studies.

Avecho Biotechnology is on the cusp of completing patient dosing in its pivotal Phase III CBD insomnia trial, backed by a recent $2.5 million capital raise and patent allowances in the US and Europe.

Anson Resources has kicked off a revised drilling program targeting lithium brines in Utah and secured a $14 million capital raise, alongside a key offtake agreement for its Green River Lithium Project.

Prominence Energy has completed its acquisition of the Gawler Natural Hydrogen Project, gaining a significant foothold in Australia's emerging natural hydrogen and helium sector. The company is advancing technical evaluations and preparing for early 2026 field surveys to validate its promising geological prospects.

InhaleRx Limited has progressed its clinical trials for three drug candidates targeting cancer pain, panic disorder, and treatment-resistant depression, while securing additional funding and preparing for a company rebrand.